The latter illness appears to be due to frameshift mutations causing nonsense-mediated decay and a loss-of-function effect, which differs considerably from the effects of missense mutations and altered post-translational modification of FUS that lead to ALS and FTLD, which are the focus of the present review. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.